Clinical Trial

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma

First of Multiple Planned Global Submissions for Lifileucel in 2024 and 2025 Key Step in Global Expansion to Address >20,000…

1 year ago

cbdMD Announces Publication of Human Clinical Trial Data

Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one…

1 year ago

IoT in Healthcare Market: Digitization Surge to Propel Valuation Beyond $926.9B by 2031 | SkyQuest Technology

WESTFORD, Mass., June 27, 2024 /PRNewswire/ -- According to SkyQuest, the global IoT in Healthcare Market size was valued at USD…

1 year ago

Lindus Health Launches Bespoke “All-in-One Medical Device CRO” Offering for Medical Device Clinical Trials

NEW YORK, June 27, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life…

1 year ago

RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services

SEATTLE, June 27, 2024 /PRNewswire/ -- RareCyte, Inc. ("RareCyte" or "the Company") a Life Sciences company providing advanced Precision Biology…

1 year ago

The Caris Precision Oncology Alliance Welcomes Leading Cancer Center

Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by…

1 year ago

Genflow Biosciences Plc Announces Result of AGM

LONDON, UNITED KINGDOM / ACCESSWIRE / June 27, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging…

1 year ago

NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson’s Disease Treatments

ZURICH, SWITZERLAND / ACCESSWIRE / June 27, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

1 year ago

FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia

TORONTO, ON / ACCESSWIRE / June 27, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to…

1 year ago

Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform

First-of-its-kind stall-side testing to enable rapid, life-saving decisions for equine veterinarians ANN ARBOR, MI / ACCESSWIRE / June 27, 2024…

1 year ago